- Home
- CCCC vs SANG Comparison
CCCC vs SANG Comparison
Compare CCCC & SANG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCCC
- SANG
- Stock Information
- Founded
- CCCC 2015
- SANG 1984
- Country
- CCCC United States
- SANG Canada
- Employees
- CCCC N/A
- SANG N/A
- Industry
- CCCC Biotechnology: Pharmaceutical Preparations
- SANG Computer Software: Programming Data Processing
- Sector
- CCCC Health Care
- SANG Technology
- Exchange
- CCCC Nasdaq
- SANG Nasdaq
- Market Cap
- CCCC 244.9M
- SANG 212.3M
- IPO Year
- CCCC 2020
- SANG 2021
- Fundamental
- Price
- CCCC $3.01
- SANG $5.82
- Analyst Decision
- CCCC Buy
- SANG
- Analyst Count
- CCCC 5
- SANG 0
- Target Price
- CCCC $11.60
- SANG N/A
- AVG Volume (30 Days)
- CCCC 1.8M
- SANG 11.7K
- Earning Date
- CCCC 03-04-2025
- SANG 02-05-2025
- Dividend Yield
- CCCC N/A
- SANG N/A
- EPS Growth
- CCCC N/A
- SANG N/A
- EPS
- CCCC N/A
- SANG N/A
- Revenue
- CCCC $33,668,000.00
- SANG $241,243,000.00
- Revenue This Year
- CCCC $75.59
- SANG N/A
- Revenue Next Year
- CCCC N/A
- SANG $3.21
- P/E Ratio
- CCCC N/A
- SANG N/A
- Revenue Growth
- CCCC 65.45
- SANG N/A
- 52 Week Low
- CCCC $2.79
- SANG $3.78
- 52 Week High
- CCCC $11.88
- SANG $7.99
- Technical
- Relative Strength Index (RSI)
- CCCC 33.55
- SANG 33.78
- Support Level
- CCCC $2.79
- SANG $6.17
- Resistance Level
- CCCC $3.38
- SANG $6.43
- Average True Range (ATR)
- CCCC 0.20
- SANG 0.36
- MACD
- CCCC -0.03
- SANG -0.11
- Stochastic Oscillator
- CCCC 23.66
- SANG 23.79
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.
About SANG Sangoma Technologies Corporation
Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic centers: USA and Other countries. Key revenue is generated from USA.